Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2000
10/19/2000CA2370489A1 49 human secreted proteins
10/19/2000CA2370189A1 48 human secreted proteins
10/19/2000CA2370131A1 62 human secreted proteins
10/19/2000CA2370112A1 Uncoupling proteins
10/19/2000CA2370039A1 Apoptosis-associated gene
10/19/2000CA2370000A1 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin
10/19/2000CA2369976A1 The novel antisense-oligos with better stability and antisense effect
10/19/2000CA2369822A1 Novel human voltage-gated potassium channel
10/19/2000CA2369817A1 Production of attenuated negative stranded rna virus vaccines from cloned nucleotide sequences
10/19/2000CA2369578A1 Compounds and methods for therapy and diagnosis of lung cancer
10/19/2000CA2369454A1 Uses of mammalian ox2 protein and related reagents
10/19/2000CA2369413A1 Transmembrane protein expressed in prostate and other cancers
10/19/2000CA2369384A1 Prostate-restricted gene 30p3c8 expressed in prostate cancer
10/19/2000CA2369262A1 Pulmonary administration of dry powder formulations for treating infertility
10/19/2000CA2369200A1 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
10/19/2000CA2369156A1 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding 4e-bp1
10/19/2000CA2369148A1 Anchored strand displacement amplification on an electronically addressable microchip
10/19/2000CA2368953A1 Proteins related to gaba metabolism
10/19/2000CA2368903A1 Detection of chromosome copy number changes to distinguish melanocytic nevi from malignant melanoma
10/19/2000CA2368648A1 Estrogen receptors and bone
10/19/2000CA2366643A1 Method for mapping a dna molecule comprising an ad infinitum amplification step
10/19/2000CA2366520A1 Anti-bacterial vaccine compositions
10/19/2000CA2366359A1 Novel essential bacterial genes and their proteins
10/19/2000CA2365996A1 Electronically mediated nucleic acid amplification in nasba
10/19/2000CA2365984A1 Antisense oligonucleotides comprising universal and/or degenerate bases
10/19/2000CA2365980A1 Amplification and sequencing primer pairs and use thereof
10/19/2000CA2365945A1 Products and methods for treating ptp lar related diseases
10/19/2000CA2365929A1 Novel method for identifying antibacterial compounds
10/19/2000CA2365919A1 Cyclic gmp dependent protein kinase as a chemotherapeutic target for antiprotozoal agents
10/19/2000CA2365918A1 49 human secreted proteins
10/19/2000CA2365917A1 Bone morphogenic proteins
10/19/2000CA2365916A1 Novel lipoxygenase proteins and polynucleotides encoding the same
10/19/2000CA2365915A1 Recombinant toxin a/toxin b vaccine against clostridium difficile
10/19/2000CA2365914A1 Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
10/19/2000CA2365913A1 Tumor necrosis factor receptor homologs and nucleic acids encoding the same
10/19/2000CA2365912A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
10/19/2000CA2365911A1 Recombinant and mutant adenoviruses derived of bovine adenovirus type 1
10/19/2000CA2365910A1 Human proteins and polynucleotides encoding them
10/19/2000CA2365908A1 Reagents and methods for identifying and modulating expression of genes regulated by p21
10/19/2000CA2365906A1 Carotene hydroxylase and method for producing xanthophyll derivatives
10/19/2000CA2365905A1 48 human secreted proteins
10/19/2000CA2365901A1 Tissue-specific and pathogen-specific toxic agents and ribozymes
10/19/2000CA2365623A1 Tyrosine kinase substrate (tks) proteins
10/19/2000CA2365522A1 48 human secreted proteins
10/19/2000CA2364690A1 Novel transduction molecules and methods for using same
10/19/2000CA2364577A1 Regulation of repressor genes using nucleic acid molecules
10/19/2000CA2364572A1 Pcr-based cloning method
10/19/2000CA2364565A1 Glucose dehydrogenases
10/19/2000CA2364541A1 Genes associated with diseases of the kidney
10/19/2000CA2364536A1 Fragments of virus protein 2 or 3 of polyoma virus, as vehicules for active substances
10/19/2000CA2360318A1 A second mammalian tankyrase
10/18/2000EP1045037A1 Plant cell identification system
10/18/2000EP1045036A2 Methods and devices for performing analysis of a nucleic acid sample
10/18/2000EP1045034A2 Amplification and detection of shiga-like toxin II producing organisms
10/18/2000EP1045033A2 Amplification and detection of shiga-like toxin I producing organisms
10/18/2000EP1045032A2 Amplification and detection of salmonella spp
10/18/2000EP1045031A2 Amplification and detection of Yersinia enterocolitica
10/18/2000EP1045030A2 Amplification and detection of campylobacter jejuni and campylobacter coli
10/18/2000EP1045028A1 Deoxyribonucleases
10/18/2000EP1045027A1 Novel gene having reverse transcriptase motif
10/18/2000EP1045026A1 A transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding
10/18/2000EP1044987A2 Gapped 2'-modified oligonucleotides
10/18/2000EP1044986A2 Amplification and detection of shigella spp. and enteroinvasive strains of escherichia coli
10/18/2000EP1044984A2 Kit for recovering RNA
10/18/2000EP1044605A1 Gene mutant animals
10/18/2000EP1044417A1 Methods and apparatus for performing sequence homology detection
10/18/2000EP1044375A1 Method comprising capture molecule fixed on disc surface
10/18/2000EP1044283A1 Fluorometric method for monitoring and detecting nucleic acid amplification
10/18/2000EP1044280A1 SELECTIVE KILLING AND DIAGNOSIS OF p53?+ NEOPLASTIC CELLS
10/18/2000EP1044279A1 Plants with modified growth
10/18/2000EP1044278A1 Biosynthesis of medium chain length polyhydroxyalkanoates
10/18/2000EP1044277A2 Recombinant, active caspases and uses thereof
10/18/2000EP1044276A2 Proteases from gram positive organisms
10/18/2000EP1044275A1 Mammalian matrix-type metalloprotease
10/18/2000EP1044274A2 Adenoviral vectors with modified capsid proteins
10/18/2000EP1044273A2 COMPOSITIONS DERIVED FROM $i(MYCOBACTERIUM VACCAE) AND METHODS FOR THEIR USE
10/18/2000EP1044272A2 Method for controlling the division and/or elongation of eukariotic cells
10/18/2000EP1044271A1 Il-1 delta dna and polypeptides
10/18/2000EP1044270A2 Apoptosis inducing molecule ii
10/18/2000EP1044269A1 Human vps35/mem3-related protein
10/18/2000EP1044268A1 Novel sequence variants of the human beta2-adrenergic receptor gene and use thereof
10/18/2000EP1044267A2 Novel nucleic acid and polypeptide with homology to the tnf-receptors
10/18/2000EP1044266A2 Human signal peptide-containing proteins
10/18/2000EP1044265A1 Dna encoding a gaba br2 polypeptide and uses thereof
10/18/2000EP1044264A2 Branched chain amino acid biosynthetic enzymes
10/18/2000EP1044263A2 CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS
10/18/2000EP1044262A1 Sex-specific insemination of mammals with low number of sperm cells
10/18/2000EP1044220A1 Secreted proteins and polynucleotides encoding them
10/18/2000EP1044219A1 DNA MOLECULES ENCODING HUMAN NUCLEAR RECEPTOR PROTEIN, nNR5
10/18/2000EP1044218A1 Nucleic acids encoding transferrin receptor-like proteins and products related thereto
10/18/2000EP1044217A2 Sag: sensitive to apoptosis gene
10/18/2000EP1044216A1 DNA MOLECULES ENCODING HUMAN NUCLEAR RECEPTOR PROTEINS, nNR7 AND nNR7-1
10/18/2000EP1044212A1 Human fk506 binding proteins
10/18/2000EP1044211A1 36 human secreted proteins
10/18/2000EP1044210A1 Human dendriac and brainiac-3
10/18/2000EP1044194A1 Receptor with an affinity for compounds of the oxazoline class
10/18/2000EP1044014A1 Agent for treating allergic or hypersensitivity condition
10/18/2000EP0876385B1 Topiramate immunoassay, as well as analogs and antibodies
10/18/2000EP0797778B1 A method for preparing non-proteinaceous strongly negatively charged macrobiomolecules, which are linked to plastic
10/18/2000EP0577666B1 Polypeptides from mycobacterium paratuberculosis